28
Oct
2025

SAPTAGIR LABORATORIES PRIVATE LIMITED

Exhibitor at CPHI Frankfurt 2025 stand 12.0D29, API
About Us

We, Saptagir Laboratories make high-quality APIs, niche intermediates, specialty chemicals and reagents. We are trusted suppliers to 5 of the top 10 global generics companies. 

Incorporated in 2016, we are a constituent unit of the SAPTAGIR GROUP with a history of more than 30 years and the largest single manufacturer of Synthetic Camphor and Aromatic Terpene chemicals in India and a leading supplier globally. We are the world’s only fully backward integrated manufacturers of Camphor Sulphonic Acid.


Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2021
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 12.0D29, API

Products Featured at CPHI Frankfurt 2025

  • Zavegepant

    Product Zavegepant

    Zavegepant is a medication used for the treatment of migraine. Zavegepant is a calcitonin gene-related peptide receptor antagonist. It is sprayed into the nose.
  • Camphor

    Product Camphor

    Camphor is an antibacterial, antifungal, and anti-inflammatory agent, used to treat skin conditions, improve respiratory function, and relieve pain.
  • Edoxaban

    Product Edoxaban

     Edoxaban is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation.
  • Ezetimibe

    Product Ezetimibe

    Ezetimibe is a medication used to treat high blood cholesterol and certain other lipid abnormalities.
  • Opicapone

    Product Opicapone

     Opicapone is used to treat the symptoms of Parkinson's disease, a condition that causes low levels of dopamine in the brain. 
  • Tafamidis

    Product Tafamidis

    Tafamidis is a medication used to treat transthyretin-mediated amyloidosis, a certain type of heart failure.